SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-099847
Filing Date
2017-03-28
Accepted
2017-03-28 16:34:03
Documents
3
Period of Report
2017-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d365712d8k.htm 8-K 16267
2 EX-99.1 d365712dex991.htm EX-99.1 129271
3 GRAPHIC g365712ex991new.jpg GRAPHIC 29629
  Complete submission text file 0001193125-17-099847.txt   187428
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 17719360
SIC: 2834 Pharmaceutical Preparations